P
P02CA51 Mebendazole, combinations
[P02CA] Benzimidazole derivatives
[P02C] ANTINEMATODAL AGENTS
[P02] ANTHELMINTICS
[P] Antiparasitic products, insecticides and repellents
P02CA01 Mebendazole
[P02CA] Benzimidazole derivatives
[P02C] ANTINEMATODAL AGENTS
[P02] ANTHELMINTICS
[P] Antiparasitic products, insecticides and repellents
Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
MEMBRANE POTENTIAL | 2.45±0.34 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
MEMBRANE POTENTIAL | 2.34 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
MEMBRANE POTENTIAL | rat | hepatocytes | MMP assay | Negative | IC50 | 163 | ||
Pictogram | Signal | Statements | Precautionary Statement Codes |
---|---|---|---|
Warning |
Aggregated GHS information provided by 73 companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. H302 (98.63%): Harmful if swallowed [Warning Acute toxicity, oral] H400 (13.7%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P264, P270, P273, P301+P312, P330, P391, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) | |
Organism | Test type | Route | Dose (normalized dose) | Effect | Source |
---|---|---|---|---|---|
domestic animals - goat/sheep | LD50 | oral | > 80mg/kg (80mg/kg) | United States Patent Document. Vol. #3657267, | |
chicken | LD50 | unreported | > 40mg/kg (40mg/kg) | United States Patent Document. Vol. #3657267, | |
cat | LD50 | oral | > 640mg/kg (640mg/kg) | Toxicology and Applied Pharmacology. Vol. 24, Pg. 371, 1973. | |
rat | LD50 | oral | 714mg/kg (714mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 19, Pg. 735, 1988. | |
mouse | LD50 | intraperitoneal | 712mg/kg (712mg/kg) | Meditsinskaya Parazitologiya i Parazitarnye Bolezni. Medical Parasitology and Parasitic Diseases. Vol. 48(4), Pg. 29, 1979. | |
rat | LD50 | intramuscular | 350mg/kg (350mg/kg) | Drugs in Japan Vol. -, Pg. 1207, 1990. | |
guinea pig | LD50 | oral | > 1280mg/kg (1280mg/kg) | Toxicology and Applied Pharmacology. Vol. 24, Pg. 371, 1973. | |
dog | LD | intramuscular | > 2gm/kg (2000mg/kg) | Drugs in Japan Vol. -, Pg. 1207, 1990. | |
dog | LD50 | oral | 1280mg/kg (1280mg/kg) | Drugs in Japan Vol. -, Pg. 1207, 1990. | |
rabbit | LD50 | oral | > 640mg/kg (640mg/kg) | Toxicology and Applied Pharmacology. Vol. 24, Pg. 371, 1973. | |
mouse | LD50 | oral | 620mg/kg (620mg/kg) | Meditsinskaya Parazitologiya i Parazitarnye Bolezni. Medical Parasitology and Parasitic Diseases. Vol. 47(6), Pg. 48, 1978. | |
(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester | (5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester | (5-benzoyl-1(3)H-benzoimidazol-2-yl)-carbamic acid methyl ester; |
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester | 2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI) | 31431-39-7 |
431M397 | 5-Benzoyl-2-benzimidazolecarbamic acid methyl ester | 5-Benzoyl-2-benzimidazolecarbamic acid methyl ester |
5-Benzoyl-2-benzimidazolecarbamic acid, methyl ester | 5-benzoyl-1H-benzimidazol-2-yl carbamic acid methyl ester | 81G6I5V05I |
A820852 | AB00052203 | AB00052203-09 |
AB00052203_10 | AB1009303 | AC-12064 |
AG-205/04588045 | AK-97348 | AKOS000539066 |
AKOS015896232 | ANW-54402 | AS-12272 |
BBL008298 | BDBM50180753 | BIDD:GT0087 |
BPBio1_000257 | BRD-K77987382-001-01-7 | BRD-K77987382-001-06-6 |
BRD-K77987382-001-08-2 | BSPBio_000233 | BSPBio_003178 |
Bantenol | Besantin | CAS-31431-39-7 |
CBDivE_010559 | CCG-39628 | CCRIS 4479 |
CHEBI:6704 | CHEMBL685 | CPD000036734 |
CS-3974 | CTK6J2930 | CTK8B6803 |
Cambridge id 5250893 | Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester | Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester (9CI) |
Carbamic acid, N-(5-benzoylbenzimidazol-2-yl)-, methyl ester | D00368 | DB00643 |
DSSTox_CID_20682 | DSSTox_GSID_40682 | DSSTox_RID_79538 |
DTXSID4040682 | DivK1c_000751 | EBD12117 |
EINECS 250-635-4 | EN300-50844 | Emverm |
Equivurm Plus | Equivurmp Plus | FT-0628179 |
FT-0628180 | HMS1536H11 | HMS1568L15 |
HMS1921F03 | HMS2090B03 | HMS2092B15 |
HMS2095L15 | HMS3259B11 | HMS3604N11 |
HMS3712L15 | HMS502F13 | HSDB 3232 |
HY-17595 | IDI1_000751 | KBio1_000751 |
KBio2_001778 | KBio2_004346 | KBio2_006914 |
KBio3_002398 | KBioGR_000712 | KBioSS_001778 |
KS-00000F1I | LS-48951 | Lomper |
M2273 | MBDZ | MCULE-4133611535 |
MFCD00057872 | MLS000028491 | MLS006011879 |
MMV003152 | Mebatreat | Mebendazol |
Mebendazol | Mebendazol [INN-Spanish] | Mebendazole (JAN/USP/INN) |
Mebendazole Polymorph C, United States Pharmacopeia (USP) Reference Standard | Mebendazole [USAN:INN:BAN:JAN] | Mebendazole [USAN:USP:INN:BAN:JAN] |
Mebendazole for system suitability, European Pharmacopoeia (EP) Reference Standard | Mebendazole, European Pharmacopoeia (EP) Reference Standard | Mebendazole, United States Pharmacopeia (USP) Reference Standard |
Mebendazole, VETRANAL(TM), analytical standard | Mebendazole, analytical standard, >=98% (HPLC) | Mebendazole,(S) |
Mebendazolum | Mebendazolum [INN-Latin] | Mebenoazole |
Mebenvet | Mebex | Mebutar |
Methyl (5-benzoyl-1H-benzo[d]imidazol-2-yl)carbamate | Methyl (6-benzoyl-1H-benzimidazol-2-yl)carbamate | Methyl 5-benzoyl benzimidazole-2-carbamate |
Methyl 5-benzoyl-2-benzimidazolecarbamate | Methyl 5-benzoyl-2-benzimidazolylcarbamate | Methyl 6-benzoyl-1H-benzimidazol-2-ylcarbamate |
Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate | Methyl N-(5-benzoyl-1Hbenzimidazol-2-yl)carbamate | Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate |
Methyl [5-(Benzoyl)benzimidazol-2-yl]carbamate | N-(6-benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester | N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle |
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French] | N-2 (5-Benzoyl-benzimidazole) carbamate de methyle | N-2 (5-Benzoyl-benzimidazole) carbamate de methyle [French] |
NC00639 | NCGC00016806-01 | NCGC00016806-02 |
NCGC00016806-03 | NCGC00016806-04 | NCGC00016806-05 |
NCGC00016806-06 | NCGC00016806-07 | NCGC00016806-08 |
NCGC00016806-09 | NCGC00016806-10 | NCGC00016806-12 |
NCGC00016806-13 | NCGC00021698-03 | NCGC00021698-04 |
NCGC00021698-05 | NCGC00021698-06 | NCGC00021698-07 |
NE41992 | NINDS_000751 | NSC 184849 |
NSC-184849 | NSC-757838 | NSC184849 |
NSC757838 | Noverme | OPXLLQIJSORQAM-UHFFFAOYSA-N |
Oprea1_278237 | Oprea1_768530 | Ovitelmin |
Pantelmin | Pharmakon1600-01501110 | Prestwick0_000217 |
Prestwick1_000217 | Prestwick2_000217 | Prestwick3_000217 |
Prestwick_310 | Probes1_000013 | Probes2_000149 |
Q422194 | R 17,635 | R 17635 |
R-17635 | R17635 | RTR-013370 |
SAM002548959 | SAM002589942 | SBB057003 |
SBI-0051641.P002 | SCHEMBL15860 | SMR000036734 |
SPBio_001442 | SPBio_002154 | SPECTRUM1501110 |
SR-01000003109 | SR-01000003109-2 | SR-01000003109-3 |
ST011967 | ST24047541 | STK093862 |
Spectrum2_001401 | Spectrum3_001439 | Spectrum4_000416 |
Spectrum5_001381 | Spectrum_001298 | Sufil |
TR-013370 | Telmin | TimTec1_000869 |
Tox21_110620 | Tox21_110620_1 | UNII-81G6I5V05I |
Vermicidin | Vermirax | Vermox |
Vermox (TN) | Verpanyl | Versid |
W-106901 | W-6804 | Z234895185 |
ZINC121541 | mebendazole | methoxy-N-[5-(phenylcarbonyl)benzimidazol-2-yl]carboxamide |
methoxy-N-[6-(phenylcarbonyl)benzimidazol-2-yl]carboxamide | methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate | methyl 5-benzoyl-1H-benzo[d]imidazol-2-ylcarbamate |
methyl N-(5-benzoyl-1H-1,3-benzimidazol-2-yl)carbamate | methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate | methyl N-[6-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate |
methyl [5-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate | s4610 |
DrugBank Name | Mebendazole |
DrugBank | DB00643 |
CAS Number | 31431-39-7 |
PubChem Compound | 4030 |
KEGG Compound ID | x |
KEGG Drug | D00368 |
PubChem.Substance | 46508807 |
ChEBI | 6704 |
PharmGKB | PA164776669 |
ChemSpider | 3890 |
BindingDB | 50180753.0 |
TTD | DAP000950 |
Wikipedia | Mebendazole |
DPD | 2434 |